Predictors of survival in HIV-infected patients on hemodialysis

American Journal of Nephrology

Volumn 16, Issue 4, 1996, Pages 280-286

  Perinbasekar, Saradha ^a,b,c,d   Brod Miller, Claudine ^a,b,c,d   Pal, Somnath ^a,b,c,d   Mattana, Joseph ^a,b,c,d  

^a QUEENS HOSPITAL CENTER   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Hemodialysis; HIV infection; Predictors; Survival

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; RECOMBINANT ERYTHROPOIETIN; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EDEMA; FEMALE; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; KIDNEY DISEASE; LYMPHOCYTE COUNT; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

EID: 0029928979     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169010     Document Type: Article

References (33)

1. Rao TKS, Filippone EJ, Nicastri AD, Landcs-man SH. Frank E, Chen CK, Friedman EA: Associated local and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984:310:669-673.
2. Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskovvitzt, Hensley GT, Bourgoi-gnie JJ: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 1984:101:429-434.
3. Pardo V, Meneses R, Ossa L, Jaffe DJ, Strauss J, Roth D, Bourgoignie JJ: AIDS related glomerulopathy: Occurrence in specific risk groups. Kidney Int 1987:31:1 167-1173.
4. D'Agati V, Suh J, Carbone L, Cheng J, Appel G: Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 1989:35:1358-1370.
5. Rao TKS: Human immunodeficiency virus (HIV) associated nephropathy. Annu Rev Med 1991;42:391-401.
6. Bourgoignie JJ, Meneses R, Ortiz C, Jaffe D, Pardo V: The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 1988;12:131-137.
7. Bourgoignie JJ: Renal complications of human immunodeficiency virus type 1. Kidney Int 1990;37:1571-1584.
8. Kimmel PL, Fcrreira-Centeno, Farkas-Szal-lase, Abraham AA, Garrett CT: Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 1992:43:1347-1352.
9. Marcus R, Favcro MS, Bancrjecs S, Solomon SL, Bell DM, Jarvis WR, Martonc WJ (The Cooperative Dialysis Study Group): Prevalence and incidence of human immunodeficiency virus among patients undergoing longterm hemodialysis. Am J Med 1991:90:614-619.
10. Sehoenfeld P, Feduska NJ: Acquired immunodeficiency syndrome and renal disease: Report of the National Kidney Foundation National Institute of Health Task Force on AIDS and Kidney Disease. Am J Kidney Dis 1990; 151:14-25.
11. Perez G, Ortiz-Intcrian C, Lee H, et al: Human immunodeficiency virus and human T-cell leukemia virus type 1 in patients undergoing maintenance hemodialysis in Miami. Am J Kidney Dis 1989:14:39-43.
12. Reiser IW, Shapiro WB, Porush JG: The incidence and epidemiology of human immunodeficiency virus infection in 320 patients treated in an inner-city hemodialysis center. Am J Kidney Dis 1990:16:26-31.
13. Rao TKS, Friedman EA, Nicastri AD: The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987: 316:1062-1068.
14. Ortiz C, Meneses R, Jaftc D, et al: Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 1988:34:248-253.
15. Kimmel PL, Umana WO, Simmens SJ, Watson J, Bosch JP: Continuous ambulatory peritoneal dialysis and survival of HIV-infected patients with end-stage renal disease. Kidney Int 1993;44:373-378.
16. Tebbcn JA, Rigsby MO, Selwyn PA, Brennan N, Kligcr K., Finkelstein FO: Outcome of HIV-infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 1993:44:191-198.
17. Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992:41 (No RR-17).
18. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in Macleod CM (ed): Evaluation of Chemotherapeutic Agents. New York. Columbia University Press, 1949. pp 191-205.
19. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966:50:163-170.
20. Cox DR: Regression models and life tables. J R Stat Soc 1972:34(serB): 187-220.
21. SAS Institute: Statistical Applied Software 6.0: SAS/STAT User's Guide. Cary. SAS Institute. 1992.
22. Rabeneck I, Wray NP: Predicting the outcomes of human immunodeficiency virus infection. Arch Intern Med 1993:153:2749-2755.
23. Cohen IS, Anderson DW, Virmani R, et al: Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med 1986:315:628-630.
24. Kaminski HJ. Kutzman M. Wicst PM. et al: Cardiomyopathy associated with the acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 1988;1:105-110.
25. Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H: Cardiac manifestations of human immunodeficiency virus infection: A two-dimensional echoesrdiographic study. J Am Coll Cardiol 1989;13:1030-1036.
26. Kinney EL: Cardiac complications in AIDS: Which are significant, which to treat. J C'rit Illness 1989;4:49-57.
27. Chao CC, Hu S, Molitor TW, Zhou Y, et al: Morphine potentiates transforming growth fac-tor-beia release from peripheral blood mononuclear cell cultures. J Pharmacol Exp Ther 1992:262:19-24.
28. Peterson PK, Gekker G, Chao CC, Schut R, Molitor TW, Balfour B. Jr: Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. J Immunol 1991: 146:81-84.
29. Mattana J, Gibbons N, Singhal PC: Cocaine interacts w ith macrophages to modulate mes-angial cell proliferation. J Pharmacol Exp Ther 1994:271:311-318.
30. Lowrie EG, Liu NL: Death risk of hemodialysis patients: The predictive value of commonly measured variables and evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
31. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305:1176-1181.
32. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-534.
33. Iscki I, Kawazoc N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidnev Int 1993:44:115-119